Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent. Xing Y, Chen R, Li F, Xu B, et al. Virology 2023;586:91-104.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xing Y, Chen R, Li F, Xu B, et al. Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent. Virology 2023;586:91-104.
PMID: 37506590